Polyomavirus in renal transplantation: A hot problem

Transplantation

Volumn 85, Issue 7 SUPPL., 2008, Pages

  Bonvoisin, Catherine ^a   Weekers, Laurent ^a   Xhignesse, Patricia ^a   Grosch, Stéphanie ^a   Milicevic, Miroslav ^a   Krzesinski, Jean Marie ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

BK virus nephropathy; Cidofovir; Decoy cell; Leflunomide; Renal transplantation

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; ACICLOVIR; AMANTADINE; CIDOFOVIR; CIPROFLOXACIN; CYCLOSPORIN; CYTARABINE; FOSCARNET; GANCICLOVIR; GATIFLOXACIN; IMMUNOGLOBULIN; LEFLUNOMIDE; LEVOFLOXACIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAPAMYCIN; RIBAVIRIN; STEROID; TACROLIMUS; TERIFLUNOMIDE; TROVAFLOXACIN; VIDARABINE; VIRUS DNA; VIRUS T ANTIGEN;

ABSENCE OF SIDE EFFECTS; ANTIVIRAL THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CYTODIAGNOSIS; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG MEGADOSE; DRUG METABOLISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GOLD STANDARD; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; INFECTION RISK; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; LOADING DRUG DOSE; LOW DRUG DOSE; NEPHROTOXICITY; POLYMERASE CHAIN REACTION; POLYOMA VIRUS; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RETRANSPLANTATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SERODIAGNOSIS; SURGICAL INFECTION; VIRUS INFECTION; VIRUS REACTIVATION;

BK VIRUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; OPPORTUNISTIC INFECTIONS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 42049103751     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318169c794     Document Type: Review

References (52)

1. Gardner SD, Mackenzie EF, Smith C. Prospective study of the human polyomavirus BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37: 578.
2. Gardner SD, Field AM, Coleman DV. New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 1971; 1: 1253.
3. Randhawa PS, Finkelstein S, Scantlebury V. Human polyoma-virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103.
4. Nickeleit V, Hirsch HH, Zeiler M. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324.
5. Ramos E, Darchenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145.
6. Barbanti-Brodano G, Sabbioni S, Martini F, et al. Simian virus 40 infection in humans and association with human disease: Results and hypotheses. Virology 2004; 318: 1.
7. Geetha D, Tong BC, Racusen L. Bladder carcinoma in a transplant recipient: Evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002; 73: 1933.
8. Moret H, Ingrand D. Les polyomavirus humains. Médecine Thérapeutique 1997; 6: 473.
9. Dugan AS, Eash S, Atwood W. Update on BK virus entry and intracellular trafficking. Transpl Infect Dis 2006; 8: 62.
10. Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71: 115.
11. Shah KV, Daniel R, Warszawski R. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973; 128: 784.
12. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611.
13. Boubenider S, Hiesse C, Marchand S. Post transplantation polyomavirus infection. J Nephrol 1999; 12: 24.
14. Colvin RB, Mauiyyedi S. Differential diagnosis between infection and rejection in renal allografts. Transplant Proc 2001; 33: 1778.
15. Ahuja M, Cohen EP, Dayer AM, et al. Polyomavirus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 2001; 71: 896.
16. Sachdeva M, Nada R, Jha V, et al. The high incidence of BK polyoma virus infection among renal transplant recipients in India. Transplantation 2004; 77: 429.
17. Bressollette-Bodin C, Coste-Burel M, Hourmant M, et al.Aprospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 2005; 5: 1926.
18. Buehrig CK, Lager DJ, Stegall MD. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665.
19. Drachenberg CB, Papadimitriou JC, Wali R. Improved outcome of polyoma virus allograft nephropathy with early biopsy. Transplant Proc 2004; 36: 758.
20. Binet I, Nickeleit V, Hirsch HH. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918.
21. Mengel M, Marwedel M, Radermacher J. Incidence of polyomavirus- nephropathy in renal allografts: Influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003; 18: 1190.
22. Lopez-Rocafort L, Wang C, Miller B. A prospective evaluation of BK virus infection in renal transplant patients [Abstract]. Am J Transplant 2002; 2: S260.
23. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
24. Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184: 1494.
25. Moens V, Subramaniam N, Johansen B. A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. J Virol 1994; 68: 2393.
26. Ginevri F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75: 1266.
27. Hirsch HH, Knowles W, Dickenmann M. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488.
28. Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213.
29. Merlino C, Bergallo M, Gribaudo G. Polyomavirus BK DNA quantification assay to evaluate viral load in renal transplant recipients. J Clin Virol 2003; 28: 265.
30. Vasudev B, Hariharan S, Hussain SA, et al. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 1834.
31. Nickeleit V, Hirsch HH, Binet IF. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080.
32. Holman CJ, Van Burik JA, Hinrichs SH. Specific detection of human BK polyomavirus in urine samples of immunocompromised patients. Clin Diagn Lab Immunol 2003; 10: 66.
33. Ding R, Medeiros M, Dadhania D. Non invasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK VP1 in urine. Transplantation 2002; 74: 987.
34. Nickeleit V, Klimkait T, Binet IF. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309.
35. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.
36. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplant 2004; 4: 2082.
37. Hirsch HH. Polyomavirus BK nephropathy: A (re-)emerging complication in renal transplantation. Am J Transplant 2002; 2: 25.
38. Ramos E, Drachenberg CB, Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: Experience at the university of Maryland renal transplant program. Clinical Transplants, 2002, Chapter 12:143.
39. Chapman C, Flower AJ, Durrant ST. The use of vidarabine in the treatment of human polyomavirus associated acute haemorrhagic cystitis. Bone Marrow Transplant 1991; 7: 481.
40. Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients. Transplantation 2006; 81: 117.
41. Kuypers DRJ, Vandooren AK, Lerut E, et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005; 5: 1997.
42. Vats AM, Saxena M, Randhawa P. Role of quantitative viral load and cidofovir therapy in the management of BK virus nephropathy [Abstract]. J Am Soc Nephrol 2001; 12: 950.
43. Vats A, Shapiro R, Randhawa PS. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 105.
44. Araya CE, Lew JF, Fennel RS, et al. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplantation 2006; 10: 32.
45. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006; 81: 704.
46. Randhawa PS. Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis 2005; 41: 1366.
47. Ali S, Chandraker A, Decaprio J. Inhibition of polyoma helicase activity by quinolones. J Am Soc Nephrol 2003;14: 43A.
48. Chandraker A, Ali S, Drachenberg CB, et al. Use of fluoroquinolones to treat BK infection in renal transplant recipients. Am J Transplant 2004; 4(suppl 8): 587 [abstract 1564].
49. Leung AYH, Chan MTL, Yuen KY, et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528.
50. Ramos E, Vincenti F, Lu WX. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation 2004; 77: 131.
51. Ginevri F, Pastorino N, De Santis R, et al. Retransplantation after kidney graft loss due to polyomavirus BK virus nephropathy: Successful outcome without original allograft nephrectomy. Am J Kidney Dis 2004; 42: 821.
52. Hirsch HH, Ramos E. Retransplantation after polyomavirus-associated nephropathy: Just do it? Am J Transplant 2006; 6: 7.